FBP1 and renal cell carcinoma: Likewise, the gluconeogenetic enzyme fructose-1,6-bisphosphatase 1 (FBP1), which was previously shown to oppose renal cell carcinoma (ccRCC) progression [17] was more than 200-fold decreased in renal oncocytomas.